Your session is about to expire
← Back to Search
Exercise Treatment Group for Sickle Cell Disease
N/A
Waitlist Available
Led By Foluso Ogunsile, MD
Research Sponsored by Memorial Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
Study Summary
This study is evaluating whether a specific exercise program may help improve health and quality of life for individuals with sickle cell disease.
Eligible Conditions
- Sickle Cell Disease
- Exercise
- Cardiovascular Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability will be measured
Feasibility will be measured
Tolerability will be measured
Trial Design
1Treatment groups
Experimental Treatment
Group I: Exercise Treatment GroupExperimental Treatment1 Intervention
Exercise Sessions
Find a Location
Who is running the clinical trial?
Memorial Healthcare SystemLead Sponsor
8 Previous Clinical Trials
1,275 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,580 Previous Clinical Trials
2,275,985 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,832 Previous Clinical Trials
47,306,336 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger